- Comments are off for this post.
NCCN Stresses the Importance of RNA Sequencing in Updated NSCLC Guidelines Translocations and gene fusions represent approximately 20% of cancer mortality globally, however the detection and targeting of these events demonstrates a revolution in personalized medicine1. Precise identification of both common and rare fusion events are critical to providing appropriate targeted therapy and improving outcomes in patients with a targetable fusion1. Recently, the National Comprehensive Cancer Network® (NCCN) published updated Clinical Practice Guidelines in Oncology for Non-Small Cell Lung Cancer (NSCLC) version 1.2020. … Read More